Watson Pharmaceuticals - M&A Summary, Ownership, and Business Overview

Medical ProductsCompany

Watson Pharmaceuticals M&A Summary

Watson Pharmaceuticals has acquired 9 companies of its own. It has also divested 1 asset.

Watson Pharmaceuticals’ largest acquisition to date was in 2012, when it acquired Pharmaco Hf. for $4.8B. Watson Pharmaceuticals has acquired in 2 different US states, and 8 countries. The Company’s most targeted sectors include life science (56%) and medical products (45%).

Watson Pharmaceuticals Ownership

Who owns Watson Pharmaceuticals?

Watson Pharmaceuticals is owned by Allergan. It was acquired on August 28, 2000.

Watson Pharmaceuticals Business Overview

Where is Watson Pharmaceuticals headquartered?

Watson Pharmaceuticals is headquartered in Florham Park, New Jersey.

How many employees does Watson Pharmaceuticals have?

Watson Pharmaceuticals has 1,325 employees.

What sector is Watson Pharmaceuticals in?

Watson Pharmaceuticals is a medical products company.

When was Watson Pharmaceuticals founded?

Watson Pharmaceuticals was founded in 1931.

M&A Summary

  • M&A Total Activity10
    • M&A Buy Activity9
    • M&A Sell Activity1
  • Total Sectors Invested 2
  • Total Countries Invested 8
  • M&A Buy/Sell Connections 5

Watson Pharmaceuticals, Inc.

100 Campus Drive,
Florham Park, New Jersey 07932
United States,
(201) 593-5500
www.actavis.com

Watson Pharmaceuticals, Inc.,is a specialty pharmaceutical company that develops, manufactures, markets and distributes branded and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 9 - - - - - 9
vol $5.5B $5.5B
Sell (0.0/yr) # 1 - - - - - 1
  10

Most Recent M&A

Company Date Value Type
Uteron Pharma SA 2013-01-23 150M USD Add-on Acquisition
Grâce-Hollogne, Belgium · www.uteron.com
Pharmaco Hf. 2012-10-31 4.8B EUR Add-on Acquisition
Hafnarfirdi,, Iceland · www.actavis.is
Ascent Pharmahealth Ltd 2012-01-24 267M AUD Divestiture
Melbourne, Australia · www.ascentpharmahealth.com.au
Eden Biopharma Group Ltd. 2010-01-28 15M USD Add-on Acquisition
Liverpool, United Kingdom
Watson Pharmaceuticals - Abbreviated New Drug Application 2009-12-02 - Divestiture
, United States
Teva Pharmaceutical Industries Ltd. - Portfolio Of Generic Pharmaceuticals 2008-11-25 36M USD Divestiture
, Israel
Sekhsaria Chemicals Ltd. 2006-04-13 - Add-on Acquisition
Mumbai,, India
Amarin Development AB 2003-10-28 15M USD Add-on Acquisition
Malmo, Sweden
Fiorinal(R) and Fioricet(R) product lines 2003-01-22 178M USD Divestiture
, United States
Somerset Pharmaceuticals, Inc. 1988-01-01 - Joint Venture
Tampa,, Florida
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 5 (56%) 481M (9%) 1 (100%) -
Medical Products 4 (44%) 5.0B (91%) - -
Total 9 $5.5B 1 -

By Geo

State/Country Buy Value Sell Value
United States 2 178M 1 -
  Florida 1 - - -
Australia 1 267M - -
Belgium 1 150M - -
Iceland 1 4.8B - -
India 1 - - -
Israel 1 36M - -
Sweden 1 15M - -
United Kingdom 1 15M - -
Domestic 2 (22%) 178M (3%) 1 (100%) -
Cross-border 7 (78%) 5.3B (97%) - -
Total 9 $5.5B 1 -

Deal Values

buy # Total
> $1B 1 $4.8B
$100M to $1B 3 $595M
< $100M 3 $66M
TOTAL $5.5B
Largest Pharmaco Hf.
$4.8B (2012-10-31)

M&A Connections

Deals
Acquired from
Strategic(s)
33%
3 (33%)
Divested to
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 204,477
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 196K M&A Transactions
  • 200K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 78K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.